Wu C H, Wang N M, Lee M F, Kao C Y, Luo S F
Department of Medical Research, Taichung Veterans General Hospital, Taiwan, Republic of China.
J Allergy Clin Immunol. 1998 Jun;101(6 Pt 1):832-40. doi: 10.1016/S0091-6749(98)70312-4.
Previously, we have identified the 28 and 32 kd proteins as additional important allergens from the American cockroach (Periplaneta americana) Cr-PII allergenic fraction.
The aim of this study was the cloning of P. americana Cr-PII allergens.
A lambdagt22A cDNA library constructed from P. americana mRNA was packaged into Escherichia coli Y1090 (r-), and clones recognized by murine anti-Cr-PII monoclonal antibodies and human IgE antibodies were isolated, sequenced, and subcloned into pET 21 and expressed in E. coli BL21(DE3).
Six Cr-PII-positive clones recognized by human IgE antibodies were isolated. Two clones, C6 and C17, were sequenced, and we found encoding proteins of 228 and 274 amino acids with no cysteine or any potential N-glycosylation site, with predicted masses of 25.8 and 31.14 kd, respectively. Both molecules contain internal repeated sequences with a 94% identity between them. C6 and C17 showed 59% and 77.3% skin reactivities, respectively, on 22 cockroach-sensitive atopic patients. Both clones were found to have 28.9% to 31.8% identities to ANG12 protein, a precursor of the African malaria mosquito (Anopheles gambiae) and 82.7% to 85.1% identity to a nucleotide sequence of the German cockroach (Blattella germanica) Bla g Bd90K allergen. The anti-C6 and anti-C17 antibodies were able to recognize Cr-PII, recombinant proteins, five commercial American extracts, and two German cockroach extracts. Moreover, the binding of anti-C6 and anti-C17 antibodies to recombinant protein can be inhibited by B. germanica crude extract. Furthermore, Northern blot analyses have shown that B. germanica mRNAs could be detected by both cDNA probes.
Our findings provide the first evidence of antigenic cross-reactivity between P. americana and B. germanica allergens on molecular levels. The results will be a great aid in facilitating the epitope mapping and improving diagnostic and therapeutic reagents for both cockroach species.
此前,我们已鉴定出28kd和32kd蛋白是来自美洲大蠊(Periplaneta americana)变应原Cr-PII组分中的另外两种重要变应原。
本研究旨在克隆美洲大蠊Cr-PII变应原。
用美洲大蠊mRNA构建的λgt22A cDNA文库包装到大肠杆菌Y1090(r-)中,分离出被鼠抗Cr-PII单克隆抗体和人IgE抗体识别的克隆,进行测序,再亚克隆到pET 21中并在大肠杆菌BL21(DE3)中表达。
分离出6个被人IgE抗体识别的Cr-PII阳性克隆。对其中两个克隆C6和C17进行测序,发现编码的蛋白分别含228和274个氨基酸,无半胱氨酸或任何潜在的N-糖基化位点,预测分子量分别为25.8kd和31.14kd。这两种分子均含有内部重复序列,二者间有94%的同一性。在22名对蟑螂敏感的特应性患者身上,C6和C17的皮肤反应性分别为59%和77.3%。发现这两个克隆与非洲疟蚊(Anopheles gambiae)的前体ANG12蛋白有28.9%至31.8%的同一性,与德国小蠊(Blattella germanica)Bla g Bd90K变应原的核苷酸序列有82.7%至85.1%的同一性。抗C6和抗C17抗体能够识别Cr-PII、重组蛋白、五种市售美洲大蠊提取物和两种德国小蠊提取物。此外,德国小蠊粗提物可抑制抗C6和抗C17抗体与重组蛋白的结合。此外,Northern印迹分析表明,两种cDNA探针均可检测到德国小蠊的mRNA。
我们的研究结果首次在分子水平上证明了美洲大蠊和德国小蠊变应原之间存在抗原交叉反应性。这些结果将极大地有助于确定表位并改进这两种蟑螂的诊断和治疗试剂。